Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Byun

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.
Investigative and Clinical Urology|March 4, 2022
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zoneHo Won Kang, Young Joon Byun, Sung Min Moon, et al.
Cancer Genetics|November 11, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissuesChuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.
Cancer Genetics|December 9, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]Chuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.
Urologic Oncology|December 19, 2020
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancerXuan-Mei Piao, Ho Won Kang, Pildu Jeong, et al.
Clinical Genitourinary Cancer|March 25, 2018
Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder CancerHo Won Kang, Sung Pil Seo, Young Joon Byun, et al.
Investigative and Clinical Urology|April 9, 2021
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancerYoung Joon Byun, Xuan Mei Piao, Pildu Jeong, et al.
Prostate International|October 26, 2020
Parathyroid hormone is associated with prostate cancerWon Tae Kim, Woo Jin Bang, Sung Pil Seo, et al.
Journal of Korean Medical Science|May 18, 2019
Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell CarcinomaHo Won Kang, Hongyong Park, Sung Pil Seo, et al.
Oncology Letters|January 4, 2020
A novel tumor suppressing gene, <i>ARHGAP9</i>, is an independent prognostic biomarker for bladder cancerXuan-Mei Piao, Pildu Jeong, Chunri Yan, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.
Investigative and Clinical Urology|March 4, 2022
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zoneHo Won Kang, Young Joon Byun, Sung Min Moon, et al.
Cancer Genetics|November 11, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissuesChuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.
Cancer Genetics|December 9, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]Chuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.
Urologic Oncology|December 19, 2020
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancerXuan-Mei Piao, Ho Won Kang, Pildu Jeong, et al.
Clinical Genitourinary Cancer|March 25, 2018
Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder CancerHo Won Kang, Sung Pil Seo, Young Joon Byun, et al.
Investigative and Clinical Urology|April 9, 2021
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancerYoung Joon Byun, Xuan Mei Piao, Pildu Jeong, et al.
Prostate International|October 26, 2020
Parathyroid hormone is associated with prostate cancerWon Tae Kim, Woo Jin Bang, Sung Pil Seo, et al.
Journal of Korean Medical Science|May 18, 2019
Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell CarcinomaHo Won Kang, Hongyong Park, Sung Pil Seo, et al.
Oncology Letters|January 4, 2020
A novel tumor suppressing gene, <i>ARHGAP9</i>, is an independent prognostic biomarker for bladder cancerXuan-Mei Piao, Pildu Jeong, Chunri Yan, et al.
Pageof 4